Effect  ||| S:0 E:7 ||| NN
of  ||| S:7 E:10 ||| IN
a  ||| S:10 E:12 ||| DT
120  ||| S:12 E:16 ||| CD
km  ||| S:16 E:19 ||| CD
endurance  ||| S:19 E:29 ||| JJ
race  ||| S:29 E:34 ||| NN
on  ||| S:34 E:37 ||| IN
plasma  ||| S:37 E:44 ||| NN
and  ||| S:44 E:48 ||| CC
muscular  ||| S:48 E:57 ||| JJ
neutrophil  ||| S:57 E:68 ||| JJ
elastase  ||| S:68 E:77 ||| NN
and  ||| S:77 E:81 ||| CC
myeloperoxidase  ||| S:81 E:97 ||| JJ
concentrations  ||| S:97 E:112 ||| NNS
in  ||| S:112 E:115 ||| IN
horses  ||| S:115 E:122 ||| NNS
Intense  ||| S:122 E:130 ||| JJ
physical  ||| S:130 E:139 ||| JJ
exercise  ||| S:139 E:148 ||| NN
can  ||| S:148 E:152 ||| MD
induce  ||| S:152 E:159 ||| VB
the  ||| S:159 E:163 ||| DT
degranulation  ||| S:163 E:177 ||| NN
of  ||| S:177 E:180 ||| IN
neutrophils  ||| S:180 E:192 ||| NNS
leading  ||| S:192 E:200 ||| VBG
to  ||| S:200 E:203 ||| TO
an  ||| S:203 E:206 ||| DT
increase  ||| S:206 E:215 ||| NN
in  ||| S:215 E:218 ||| IN
plasma  ||| S:218 E:225 ||| JJ
concentration  ||| S:225 E:239 ||| NN
of  ||| S:239 E:242 ||| IN
the  ||| S:242 E:246 ||| DT
neutrophil  ||| S:246 E:257 ||| FW
marker  ||| S:257 E:264 ||| FW
enzymes  ||| S:264 E:272 ||| FW
myeloperoxidase  ||| S:272 E:288 ||| FW
( ||| S:288 E:289 ||| -LRB-
MPO ||| S:289 E:292 ||| NNP
)  ||| S:292 E:294 ||| -RRB-
and  ||| S:294 E:298 ||| CC
elastase  ||| S:298 E:307 ||| NNS
( ||| S:307 E:308 ||| -LRB-
ELT ||| S:308 E:311 ||| NNP
) ||| S:311 E:312 ||| -RRB-
.  ||| S:312 E:314 ||| .
These  ||| S:314 E:320 ||| DT
enzymes  ||| S:320 E:328 ||| NNS
have  ||| S:328 E:333 ||| VBP
pro-oxidative  ||| S:333 E:347 ||| JJ
and  ||| S:347 E:351 ||| CC
pro-inflammatory  ||| S:351 E:368 ||| JJ
properties  ||| S:368 E:379 ||| NNS
and  ||| S:379 E:383 ||| CC
may  ||| S:383 E:387 ||| MD
play  ||| S:387 E:392 ||| VB
a  ||| S:392 E:394 ||| DT
role  ||| S:394 E:399 ||| NN
in  ||| S:399 E:402 ||| IN
the  ||| S:402 E:406 ||| DT
exercised-induced  ||| S:406 E:424 ||| JJ
muscular  ||| S:424 E:433 ||| JJ
damage ||| S:433 E:439 ||| NN
.  ||| S:439 E:441 ||| .
To  ||| S:441 E:444 ||| TO
measure  ||| S:444 E:452 ||| VB
MPO  ||| S:452 E:456 ||| NNP
and  ||| S:456 E:460 ||| CC
ELT  ||| S:460 E:464 ||| NNP
concentrations  ||| S:464 E:479 ||| NNS
in  ||| S:479 E:482 ||| IN
plasma  ||| S:482 E:489 ||| NN
and  ||| S:489 E:493 ||| CC
muscles  ||| S:493 E:501 ||| NNS
of  ||| S:501 E:504 ||| IN
endurance  ||| S:504 E:514 ||| JJ
horses  ||| S:514 E:521 ||| NNS
and  ||| S:521 E:525 ||| CC
to  ||| S:525 E:528 ||| TO
correlate  ||| S:528 E:538 ||| VB
them  ||| S:538 E:543 ||| PRP
to  ||| S:543 E:546 ||| TO
the  ||| S:546 E:550 ||| DT
extent  ||| S:550 E:557 ||| NN
of  ||| S:557 E:560 ||| IN
exercise-induced  ||| S:560 E:577 ||| JJ
muscular  ||| S:577 E:586 ||| JJ
damage ||| S:586 E:592 ||| NN
.  ||| S:592 E:594 ||| .
Seven  ||| S:594 E:600 ||| CD
endurance  ||| S:600 E:610 ||| CD
horses  ||| S:610 E:617 ||| NNS
qualified  ||| S:617 E:627 ||| VBN
on  ||| S:627 E:630 ||| IN
120  ||| S:630 E:634 ||| CD
km  ||| S:634 E:637 ||| CD
races  ||| S:637 E:643 ||| NNS
were  ||| S:643 E:648 ||| VBD
tested  ||| S:648 E:655 ||| VBN
in  ||| S:655 E:658 ||| IN
this  ||| S:658 E:663 ||| DT
study ||| S:663 E:668 ||| NN
.  ||| S:668 E:670 ||| .
Neutrophil  ||| S:670 E:681 ||| JJ
count ||| S:681 E:686 ||| NN
,  ||| S:686 E:688 ||| ,
serum  ||| S:688 E:694 ||| FW
creatine  ||| S:694 E:703 ||| FW
kinase  ||| S:703 E:710 ||| FW
( ||| S:710 E:711 ||| -LRB-
CK ||| S:711 E:713 ||| NNP
) ||| S:713 E:714 ||| -RRB-
,  ||| S:714 E:716 ||| ,
plasmatic  ||| S:716 E:726 ||| NN
and  ||| S:726 E:730 ||| CC
muscular  ||| S:730 E:739 ||| JJ
MPO  ||| S:739 E:743 ||| NNP
and  ||| S:743 E:747 ||| CC
ELT  ||| S:747 E:751 ||| NNP
concentrations  ||| S:751 E:766 ||| NNS
were  ||| S:766 E:771 ||| VBD
measured  ||| S:771 E:780 ||| VBN
before  ||| S:780 E:787 ||| IN
and  ||| S:787 E:791 ||| CC
2  ||| S:791 E:793 ||| CD
h  ||| S:793 E:795 ||| NN
after  ||| S:795 E:801 ||| IN
a  ||| S:801 E:803 ||| DT
120  ||| S:803 E:807 ||| CD
km  ||| S:807 E:810 ||| CD
endurance  ||| S:810 E:820 ||| JJ
race ||| S:820 E:824 ||| NN
.  ||| S:824 E:826 ||| .
The  ||| S:826 E:830 ||| DT
race  ||| S:830 E:835 ||| NN
produced  ||| S:835 E:844 ||| VBD
a  ||| S:844 E:846 ||| DT
significant  ||| S:846 E:858 ||| JJ
increase  ||| S:858 E:867 ||| NN
of  ||| S:867 E:870 ||| IN
neutrophils ||| S:870 E:881 ||| NN
,  ||| S:881 E:883 ||| ,
CK ||| S:883 E:885 ||| NNP
,  ||| S:885 E:887 ||| ,
and  ||| S:887 E:891 ||| CC
plasma  ||| S:891 E:898 ||| JJ
MPO  ||| S:898 E:902 ||| NNP
and  ||| S:902 E:906 ||| CC
ELT  ||| S:906 E:910 ||| NNP
levels ||| S:910 E:916 ||| NNS
.  ||| S:916 E:918 ||| .
A  ||| S:918 E:920 ||| DT
significant  ||| S:920 E:932 ||| JJ
correlation  ||| S:932 E:944 ||| NN
was  ||| S:944 E:948 ||| VBD
observed  ||| S:948 E:957 ||| VBN
between  ||| S:957 E:965 ||| IN
the  ||| S:965 E:969 ||| DT
MPO  ||| S:969 E:973 ||| NNP
and  ||| S:973 E:977 ||| CC
ELT  ||| S:977 E:981 ||| NNP
values  ||| S:981 E:988 ||| NNS
in  ||| S:988 E:991 ||| IN
plasma  ||| S:991 E:998 ||| NNS
( ||| S:998 E:999 ||| -LRB-
r ||| S:999 E:1000 ||| LS
( ||| S:1000 E:1001 ||| -LRB-
2 ||| S:1001 E:1002 ||| LS
)  ||| S:1002 E:1004 ||| -RRB-
=  ||| S:1004 E:1006 ||| SYM
0.92 ||| S:1006 E:1010 ||| CD
,  ||| S:1010 E:1012 ||| ,
P  ||| S:1012 E:1014 ||| NN
< ||| S:1014 E:1016 ||| SYM
0.01 ||| S:1016 E:1020 ||| CD
)  ||| S:1020 E:1022 ||| -RRB-
and  ||| S:1022 E:1026 ||| CC
in  ||| S:1026 E:1029 ||| IN
muscles  ||| S:1029 E:1037 ||| NNS
( ||| S:1037 E:1038 ||| -LRB-
r ||| S:1038 E:1039 ||| LS
( ||| S:1039 E:1040 ||| -LRB-
2 ||| S:1040 E:1041 ||| LS
)  ||| S:1041 E:1043 ||| -RRB-
=  ||| S:1043 E:1045 ||| SYM
0.89 ||| S:1045 E:1049 ||| CD
,  ||| S:1049 E:1051 ||| ,
P  ||| S:1051 E:1053 ||| NN
< ||| S:1053 E:1055 ||| SYM
0.01 ||| S:1055 E:1059 ||| CD
)  ||| S:1059 E:1061 ||| -RRB-
while  ||| S:1061 E:1067 ||| IN
plasmatic  ||| S:1067 E:1077 ||| JJ
concentrations  ||| S:1077 E:1092 ||| NNS
of  ||| S:1092 E:1095 ||| IN
MPO  ||| S:1095 E:1099 ||| NNP
and  ||| S:1099 E:1103 ||| CC
ELT  ||| S:1103 E:1107 ||| NNP
were  ||| S:1107 E:1112 ||| VBD
not  ||| S:1112 E:1116 ||| RB
significantly  ||| S:1116 E:1130 ||| RB
correlated  ||| S:1130 E:1141 ||| VBN
to  ||| S:1141 E:1144 ||| TO
muscular  ||| S:1144 E:1153 ||| VB
ones ||| S:1153 E:1157 ||| NNS
.  ||| S:1157 E:1159 ||| .
An  ||| S:1159 E:1162 ||| DT
increase  ||| S:1162 E:1171 ||| NN
of  ||| S:1171 E:1174 ||| IN
mean  ||| S:1174 E:1179 ||| JJ
concentrations  ||| S:1179 E:1194 ||| NNS
( ||| S:1194 E:1195 ||| -LRB-
±  ||| S:1195 E:1197 ||| NNP
s.e. ||| S:1197 E:1201 ||| NNP
)  ||| S:1201 E:1203 ||| -RRB-
of  ||| S:1203 E:1206 ||| IN
MPO  ||| S:1206 E:1210 ||| NNP
( ||| S:1210 E:1211 ||| -LRB-
T0 ||| S:1211 E:1213 ||| NNP
:  ||| S:1213 E:1215 ||| :
9.85  ||| S:1215 E:1220 ||| CD
±  ||| S:1220 E:1222 ||| CD
3.9 ||| S:1222 E:1225 ||| CD
,  ||| S:1225 E:1227 ||| ,
T1 ||| S:1227 E:1229 ||| NNP
:  ||| S:1229 E:1231 ||| :
228.9  ||| S:1231 E:1237 ||| FW
±  ||| S:1237 E:1239 ||| FW
95.9  ||| S:1239 E:1244 ||| FW
ng ||| S:1244 E:1246 ||| FW
/ ||| S:1246 E:1247 ||| FW
mg  ||| S:1247 E:1250 ||| FW
proteins ||| S:1250 E:1258 ||| FW
)  ||| S:1258 E:1260 ||| -RRB-
and  ||| S:1260 E:1264 ||| CC
ELT  ||| S:1264 E:1268 ||| NNP
( ||| S:1268 E:1269 ||| -LRB-
T0 ||| S:1269 E:1271 ||| NNP
:  ||| S:1271 E:1273 ||| :
8.4  ||| S:1273 E:1277 ||| CD
±  ||| S:1277 E:1279 ||| CD
2.4 ||| S:1279 E:1282 ||| CD
,  ||| S:1282 E:1284 ||| ,
T1 ||| S:1284 E:1286 ||| NNP
:  ||| S:1286 E:1288 ||| :
74.5  ||| S:1288 E:1293 ||| CD
±  ||| S:1293 E:1295 ||| CD
39.7  ||| S:1295 E:1300 ||| CD
ng ||| S:1300 E:1302 ||| CD
/ ||| S:1302 E:1303 ||| CD
mg  ||| S:1303 E:1306 ||| CD
proteins ||| S:1306 E:1314 ||| NNS
)  ||| S:1314 E:1316 ||| -RRB-
in  ||| S:1316 E:1319 ||| IN
the  ||| S:1319 E:1323 ||| DT
muscles  ||| S:1323 E:1331 ||| NNS
were  ||| S:1331 E:1336 ||| VBD
observed  ||| S:1336 E:1345 ||| VBN
after  ||| S:1345 E:1351 ||| IN
the  ||| S:1351 E:1355 ||| DT
race ||| S:1355 E:1359 ||| NN
.  ||| S:1359 E:1361 ||| .
Interestingly ||| S:1361 E:1374 ||| RB
,  ||| S:1374 E:1376 ||| ,
the  ||| S:1376 E:1380 ||| DT
individual  ||| S:1380 E:1391 ||| JJ
data  ||| S:1391 E:1396 ||| NNS
showed  ||| S:1396 E:1403 ||| VBD
large  ||| S:1403 E:1409 ||| JJ
differences  ||| S:1409 E:1421 ||| NNS
between  ||| S:1421 E:1429 ||| IN
the  ||| S:1429 E:1433 ||| DT
horses ||| S:1433 E:1439 ||| NNS
.  ||| S:1439 E:1441 ||| .
Muscular  ||| S:1441 E:1450 ||| NNP
MPO  ||| S:1450 E:1454 ||| NNP
and  ||| S:1454 E:1458 ||| CC
ELT  ||| S:1458 E:1462 ||| NNP
concentrations  ||| S:1462 E:1477 ||| NNS
were  ||| S:1477 E:1482 ||| VBD
significantly  ||| S:1482 E:1496 ||| RB
correlated  ||| S:1496 E:1507 ||| VBN
to  ||| S:1507 E:1510 ||| TO
plasma  ||| S:1510 E:1517 ||| VB
CK  ||| S:1517 E:1520 ||| JJ
levels ||| S:1520 E:1526 ||| NNS
.  ||| S:1526 E:1528 ||| .
The  ||| S:1528 E:1532 ||| DT
coefficient  ||| S:1532 E:1544 ||| NN
of  ||| S:1544 E:1547 ||| IN
correlation  ||| S:1547 E:1559 ||| NN
( ||| S:1559 E:1560 ||| -LRB-
r ||| S:1560 E:1561 ||| LS
( ||| S:1561 E:1562 ||| -LRB-
2 ||| S:1562 E:1563 ||| LS
) ||| S:1563 E:1564 ||| -RRB-
)  ||| S:1564 E:1566 ||| -RRB-
was  ||| S:1566 E:1570 ||| VBD
0.69  ||| S:1570 E:1575 ||| CD
( ||| S:1575 E:1576 ||| -LRB-
P  ||| S:1576 E:1578 ||| NNP
< ||| S:1578 E:1580 ||| SYM
0.01 ||| S:1580 E:1584 ||| CD
)  ||| S:1584 E:1586 ||| -RRB-
for  ||| S:1586 E:1590 ||| IN
MPO  ||| S:1590 E:1594 ||| NNP
and  ||| S:1594 E:1598 ||| CC
0.66  ||| S:1598 E:1603 ||| CD
( ||| S:1603 E:1604 ||| -LRB-
P  ||| S:1604 E:1606 ||| NNP
< ||| S:1606 E:1608 ||| SYM
0.01 ||| S:1608 E:1612 ||| CD
)  ||| S:1612 E:1614 ||| -RRB-
for  ||| S:1614 E:1618 ||| IN
ELT ||| S:1618 E:1621 ||| NNP
,  ||| S:1621 E:1623 ||| ,
respectively ||| S:1623 E:1635 ||| RB
.  ||| S:1635 E:1637 ||| .
Results  ||| S:1637 E:1645 ||| NNS
underline  ||| S:1645 E:1655 ||| VB
the  ||| S:1655 E:1659 ||| DT
possible  ||| S:1659 E:1668 ||| JJ
role  ||| S:1668 E:1673 ||| NN
of  ||| S:1673 E:1676 ||| IN
MPO  ||| S:1676 E:1680 ||| NNP
and  ||| S:1680 E:1684 ||| CC
ELT  ||| S:1684 E:1688 ||| NNP
in  ||| S:1688 E:1691 ||| IN
exercise-induced  ||| S:1691 E:1708 ||| JJ
muscular  ||| S:1708 E:1717 ||| JJ
damage ||| S:1717 E:1723 ||| NN
.  ||| S:1723 E:1725 ||| .
Further  ||| S:1725 E:1733 ||| JJ
studies  ||| S:1733 E:1741 ||| NNS
should  ||| S:1741 E:1748 ||| MD
investigate  ||| S:1748 E:1760 ||| VB
the  ||| S:1760 E:1764 ||| DT
effect  ||| S:1764 E:1771 ||| NN
of  ||| S:1771 E:1774 ||| IN
exercise  ||| S:1774 E:1783 ||| NN
type  ||| S:1783 E:1788 ||| NN
and  ||| S:1788 E:1792 ||| CC
intensity ||| S:1792 E:1801 ||| NN
,  ||| S:1801 E:1803 ||| ,
as  ||| S:1803 E:1806 ||| RB
well  ||| S:1806 E:1811 ||| RB
as  ||| S:1811 E:1814 ||| IN
the  ||| S:1814 E:1818 ||| DT
role  ||| S:1818 E:1823 ||| NN
of  ||| S:1823 E:1826 ||| IN
the  ||| S:1826 E:1830 ||| DT
training  ||| S:1830 E:1839 ||| NN
state  ||| S:1839 E:1845 ||| NN
on  ||| S:1845 E:1848 ||| IN
MPO  ||| S:1848 E:1852 ||| NNP
and  ||| S:1852 E:1856 ||| CC
ELT  ||| S:1856 E:1860 ||| NNP
involvement  ||| S:1860 E:1872 ||| NN
in  ||| S:1872 E:1875 ||| IN
muscular  ||| S:1875 E:1884 ||| JJ
damage ||| S:1884 E:1890 ||| NN
.  ||| S:1890 E:1892 ||| .
The  ||| S:1892 E:1896 ||| DT
assessment  ||| S:1896 E:1907 ||| NN
of  ||| S:1907 E:1910 ||| IN
the  ||| S:1910 E:1914 ||| DT
intensity  ||| S:1914 E:1924 ||| NN
of  ||| S:1924 E:1927 ||| IN
exercise-induced  ||| S:1927 E:1944 ||| JJ
neutrophilic  ||| S:1944 E:1957 ||| JJ
degranulation  ||| S:1957 E:1971 ||| NN
may  ||| S:1971 E:1975 ||| MD
have  ||| S:1975 E:1980 ||| VB
a  ||| S:1980 E:1982 ||| DT
potential  ||| S:1982 E:1992 ||| JJ
role  ||| S:1992 E:1997 ||| NN
in  ||| S:1997 E:2000 ||| IN
the  ||| S:2000 E:2004 ||| DT
monitoring  ||| S:2004 E:2015 ||| NN
of  ||| S:2015 E:2018 ||| IN
the  ||| S:2018 E:2022 ||| DT
athletic  ||| S:2022 E:2031 ||| JJ
career ||| S:2031 E:2037 ||| NN
.  ||| S:2037 E:2039 ||| .
